Mereo Biopharma Group Plc ADR’s stock market performance has been consistent.
52-week price history of MREO Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Mereo Biopharma Group Plc ADR’s current trading price is 7.42% away from its 52-week high, while its distance from the 52-week low is 356.79%. The stock’s price range for this period has remained between $1.07 and $4.55. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.04 million for the day, which was noticeably lower compared to the shares’ average daily volume of 1.18 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Mereo Biopharma Group Plc ADR (MREO) has experienced a quarterly rise of 66.82% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 751.53M and boasts a workforce of 33 employees.
Moving average and trading volume data
MREO Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MREO stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.01.
MREO Stock Stochastic Average
MREO Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Until today this year the stock’s price performance recorded an increase of 111.59%. However, over the last six months, the performance has been weaker by 32.82%. The price of MREO increased 19.80% over the last 30 days. And in the last five days, it has surged by 12.88%.
